CEN/TC 206
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 74131 | EN ISO 10993-18:2020/A1:2023 | Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process - Amendment 1: Determination of the uncertainty factor (ISO 10993-18:2020/Amd 1:2022) | Standarts spēkā |
| 32000 | LVS EN ISO 10993-14:2009 | Biological evaluation of medical devices - Part 14: Identification and quantification of degradation products from ceramics (ISO 10993-14:2001) | Standarts spēkā |
| 60133 | LVS EN ISO 10993-11:2018 | Biological evaluation of medical devices - Part 11: Tests for systemic toxicity (ISO 10993-11:2017) | Standarts spēkā |
| 38319 | EN ISO 10993-6:2016 | Biological evaluation of medical devices - Part 6: Tests for local effects after implantation (ISO/DIS 10993-6:2014) | Standarts spēkā |
| 78989 | EN ISO 10993-12:2021/A1:2025 | Biological evaluation of medical devices - Part 12: Sample preparation and reference materials - Amendment 1 (ISO 10993 12:2021/Amd 1:2025) | Standarts spēkā |
| 69998 | EN ISO 10993-2:2022 | Biological evaluation of medical devices - Part 2: Animal welfare requirements (ISO/DIS 10993-2:2020) | Standarts spēkā |
| 9493 | LVS EN ISO 10993-7:2009 | Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals (ISO 10993-7:2008) | Standarts spēkā |
| 60724 | EN ISO 10993-16:2017 | Biological evaluation of medical devices - Part 16: Toxicokinetic study design for degradation products and leachables (ISO/DIS 10993-16:2016) | Standarts spēkā |
| 67767 | EN ISO 10993-17:2023 | Biological evaluation of medical devices - Part 17: Toxicological risk assessment of medical device constituents (ISO/DIS 10993-17:2021) | Standarts spēkā |
| 67187 | EN ISO 10993-10:2023 | Biological evaluation of medical devices - Part 10: Tests for skin sensitization (ISO/DIS 10993-10:2020) | Standarts spēkā |
Displaying 161-170 of 194 results.